EUROPEAN OPPORTUNITIES TRUST PLC
Legal Entity Identifier: 549300XN7RXQWHN18849
Month end portfolio information as at 30 June 2026
Total Net Assets: £ 447,299,137
Total Assets (including drawdown bank debt): £ 447,299,137
Top Twenty Holdings
Stock Sector Country of Listing % of Total Assets (Incl Drawn down bank debt) | Infineon Technologies Information Technology Germany 7.7 | Novo Nordisk Health Care Denmark 7.5 | Genus Plc Health Care United Kingdom 6.5 | Experian Plc Industrials Ireland 6.5 | Deutsche Boerse Financials Germany 6.3 | Camurus Health Care Sweden 6.2 | ICG Plc Financials United Kingdom 5.8 | Dassault Systemes Information Technology France 5.3 | Relx Plc Industrials Netherlands 5.2 | Gaztransport Et Technigaz Energy France 4.8 | Grifols Health Care Spain 4.5 | Edenred Financials France 4.3 | Prysmian Industrials Italy 3.4 | BioMérieux Health Care France 3.1 | BAE Systems Plc Industrials United Kingdom 2.8 | Ryanair Holdings ADRs Industrials Ireland 2.8 | Wise Plc Financials United Kingdom 2.6 | VAT Group Industrials Switzerland 2.4 | CTS Eventim Communication Services Germany 2.3 | Thales Industrials France 2.2 |
Country of listing of investee companies
Country % of Total assets (including drawn down bank debt) | France 22.4 | United Kingdom 17.6 | Germany 16.3 | Ireland 9.2 | Denmark 8.3 | Sweden 6.9 | Netherlands 5.2 | Spain 4.5 | Italy 3.9 | Switzerland 3.7 | Cash/(Gearing) 2.0 |
Market Capitalisation of investee companies
Market Cap % of Total Assets (including Drawn down bank debt) | Large 83.4 | Mid 14.1 | Small 0.5 | Cash/(Gearing) 2.0 |
The Company's most recent report and accounts and further information for shareholders is published on the Company's website at www.europeanopportunitiestrust.com
Enquiries:
Devon Equity Management Limited,
Richard Pavry
020 3985 0441
enquiries@devonem.com
02 July 2026
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END PFUBXGDRRUGDGLD